CYOE Financials Monday, July 14, 2014 11:15:11 PM

CYOE Financials Monday, July 14, 2014 11:15:11 PM
CytoCore, Inc.
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 24 198 24 30
Cost of Revenue 8 104 - 1
Gross Profit 16 94 24 29
Operating Expenses
Research and Development 250 336 237 211
Sales, General and Admin. 584 1,027 1,715 1,669
Non-Recurring Items - - 651 399
Other - - - -
Operating Income (818) (1,269) (2,579) (2,250)
Income From Continuing Operations
Add'l Income/Expense Items - - (111) 334
Earnings Before Interest and Tax (818) (1,269) (2,690) (1,916)
Interest Expense 105 245 186 181
Earnings Before Tax (923) (1,514) (2,876) (2,097)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (923) (1,514) (2,876) (2,097)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (923) (1,514) (2,876) (2,097)
Preferred Stock and Other Adjustments (266) (266) (266) (266)
Net Income Applicable to Common Shareholders (1,189) (1,780) (3,142) (2,363)